Log In
Medical Policy Update for May 03, 2022
| Medical Guidelines | Reason for Update |
|---|---|
| Diagnosis and Treatment of Sacroiliac Joint Pain | References added. Related policies updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 4/2022 |
| Epidural Steroid Injections for Back Pain | Policy guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
| Facet Joint Denervation | References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director Review 4/2022. No change to policy statement |
| Hemodialysis Treatment for ESRD | Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. |
| Infertility Diagnosis and Treatment – B0006 | Codes 0664T-0670T from Billing/Coding section and investigational statement F. under “When not Covered” section: “Uterine transplant is considered investigational as a treatment of infertility” inadvertently removed during 10/19/21 update. Codes and statement re-added. |
| Intradialytic Parenteral Nutrition | Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No Change to policy statement. |
| Neural Therapy | References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
| Neurostimulation, Electrical | References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
| Percutaneous Electrical Nerve Stimulation (PENS) or Neuromodulation Therapy and Percutaneous Electrical Nerve Field Stimulation (PENFS) | References updated. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
| Prolotherapy | Related policy added. References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
| Radiofrequency Ablation of the Renal Nerves as a Treatment of Hypertension | References updated. Specialty Matched Advisory Panel review 4/2022. Medical Director review 4/2021. |
| Renal (Kidney) Transplantation | References updated. Specialty Matched Specialty Advisory Panel review 4/2022. Medical Director review 4/2022. |
| Skin and Soft Tissue Substitutes | Updated information to When Skin and Soft Tissue Substitutes are covered. Criteria to include clarification of 2nd degree burn products: “Kerecis* (formerly known as MariGen™*). |
| TENS (Transcutaneous Electrical Nerve Stimulator) | Regulatory status updated. References added. Specialty Matched Consultant Advisory Panel review 4/2022. Medical Director review 4/2022. No change to policy statement. |
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.